Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 2 7Phase 3 4Phase NA 2Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Genitourinary 2CNS 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 10Leukemia 10Myelodysplastic Syndromes 9Multiple Myeloma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Congenital Abnormalities 9Lymphoma, Follicular 8Hodgkin Disease 8Recurrence 7Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Primary Myelofibrosis 6Neoplasms, Plasma Cell 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6Burkitt Lymphoma 6Blast Crisis 6Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myeloid, Accelerated Phase 5Dendritic Cell Sarcoma, Interdigitating 5Polycythemia Vera 4Anemia, Refractory, with Excess of Blasts 4Waldenstrom Macroglobulinemia 3Thrombocythemia, Essential 3

Interventions

Cyclophosphamide 5Melphalan 4Isotretinoin 4Etoposide 4Carboplatin 4Vincristine 3Therapeutics 3Radiotherapy 3Cisplatin 3Topotecan 2Stem Cell Transplantation 2Radiotherapy, Image-Guided 2Psychiatric Rehabilitation 2Granulocyte-Macrophage Colony-Stimulating Factor 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Dexamethasone 2Calcium Dobesilate 2Busulfan 2Blood Specimen Collection 2Aprepitant 23-Iodobenzylguanidine 2sargramostim 1pegfilgrastim 1humanized 3F8 anti-GD2 monoclonal antibody 1hetrombopag 1etoposide phosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1Whole-Body Irradiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Neuroblastoma × Busulfan × Clear all
NCT00536601 2021-04-22

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Roswell Park Cancer Institute

Phase NA Completed
174 enrolled 17 charts
CNSDermatologicGenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Neuroblastoma, Recurrence, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Neuroectodermal Tumors, Primitive, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

NCT00152126 2009-02-13

Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas

St. Jude Children's Research Hospital

Phase NA Completed
26 enrolled
CNSGenitourinaryLymphoid

Lymphoma, Wilms Tumor, Neuroblastoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡